Aller au contenu principal
Profil bibliographique

Mona Selej

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

63Publications signalées
2074Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Pulmonary Hypertension Research and TreatmentsHeart Failure Treatment and ManagementCardiovascular Function and Risk FactorsChronic Obstructive Pulmonary Disease (COPD) ResearchCardiovascular Issues in Pregnancy

Les publications récentes

Accès ouvert 2025 article OpenAlex

Characteristics of Daily Walking Bouts as Valid and Reliable Indicators of Exercise Capacity in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE)

Rana Zia Ur Rehman, Federico Parisi, Noman Ashraf, Meenakshi Chatterjee et autres

ABSTRACT There is a need for objective, continuous and remote assessment of exercise capacity in patients with pulmonary arterial hypertension (PAH). Using data from the TRACE study, in which 108 adult patients with PAH were continuously monitored with a wrist‐worn accelerometer, we …

gb, us, be (code pays fourni par la source)

2 citations Pulmonary Circulation
Accès ouvert 2024 article OpenAlex

Artificial intelligence-based echocardiography assessment to detect pulmonary hypertension

Mahan Salehi, Samer Alabed, Michael Sharkey, Ahmed Maiter et autres

Background Tricuspid regurgitation jet velocity (TRJV) on echocardiography is used for screening patients with suspected pulmonary hypertension (PH). Artificial intelligence (AI) tools, such as the US2.AI, have been developed for automated evaluation of echocardiograms and can yield measurements that aid PH detection. …

gb, us (code pays fourni par la source)

15 citations ERJ Open Research
Accès ouvert 2024 article OpenAlex

SOPRANO: Macitentan in patients with pulmonary hypertension following left ventricular assist device implantation

Robert P. Frantz, Shashank Desai, Gregory A. Ewald, Verónica Franco et autres

Abstract Macitentan is a dual endothelin receptor antagonist (ERA) approved for treating pulmonary arterial hypertension (PAH). SOPRANO evaluated the efficacy and safety of macitentan versus placebo in pulmonary hypertension (PH) patients after left ventricular assist device (LVAD) implantation. SOPRANO was a phase …

us (code pays fourni par la source)

6 citations Pulmonary Circulation
Accès ouvert 2024 article OpenAlex

An electrocardiogram-based AI algorithm for early detection of pulmonary hypertension

Hilary M. DuBrock, Tyler E. Wagner, Katherine Carlson, Corinne Carpenter et autres

BACKGROUND: Early diagnosis of pulmonary hypertension (PH) is critical for effective treatment and management. We aimed to develop and externally validate an artificial intelligence algorithm that could serve as a PH screening tool, based on analysis of a standard 12-lead ECG. METHODS: …

us, in, be (code pays fourni par la source)

37 citations European Respiratory Journal
Accès ouvert 2023 article OpenAlex

Timely PAH Identification in Adults With Repaired Congenital Heart Disease? The ACHD-QuERI Registry Insights

Michael J. Landzberg, Curt J. Daniels, Paul R. Forfia, Vallerie V. McLaughlin et autres

Background: The Quality Enhancement Research Initiative (QuERI) in adults with congenital heart disease (ACHD) was developed to improve detection of pulmonary arterial hypertension (PAH) after repair of systemic-to-pulmonary arterial shunt lesions. Objectives: This study sought to standardize use of accepted criteria for …

us (code pays fourni par la source)

2 citations JACC Advances
Accès ouvert 2023 article OpenAlex

A claims‐based, machine‐learning algorithm to identify patients with pulmonary arterial hypertension

Bethany Hyde, Carly J. Paoli, Sumeet Panjabi, K. Bettencourt et autres

Many patients with pulmonary arterial hypertension (PAH) experience substantial delays in diagnosis, which is associated with worse outcomes and higher costs. Tools for diagnosing PAH sooner may lead to earlier treatment, which may delay disease progression and adverse outcomes including hospitalization and …

us, ch, be (code pays fourni par la source)

18 citations Pulmonary Circulation

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.